Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Published in: Indian Journal of Hematology and Blood Transfusion 2/2021

01-04-2021 | Fifth Disease | Original Article

Screening for Human Parvovirus B19 Infection in Egyptian Family Replacement Blood Donors

Authors: Rabab Hasanain Ahmed Hasanain, Rania M. Saleh, Fadia M. Attia, Hanaa H. Gomaa

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 2/2021

Login to get access

Abstract

Up till now, screening for human parvovirus B19 is not routine in national Egyptian blood bank strategy. Blood samples were collected from 500 healthy blood donors within the age range from 18 to 45 years old attending the blood bank of Suez Canal University Hospital, Ismailia, Egypt. Sera were separated and stored at − 20 °C. Serum samples were screened for anti-human parvovirus B19 IgM and IgG antibodies and B19 genome using ELISA and real-time PCR respectively. Frequency of B19 IgM and B19 IgG antibodies was 6.20%, and 80.20% respectively, and the prevalence of B19 genome was 3.00%. There is a high frequency of human parvovirus B19 among Egyptian blood donors; therefore, serological screening for B19 is warranted.

Literature
  1. Kaufman B, Simpson A, Rossmann M (2004) The structure of human parvovirus B19. P Natl Acad Sci USA 101:11628–11633View Article
  2. Cotmore SF, Agbandje-McKenna M, Chiorini JA et al (2014) The family parvoviridae. Arch Virol 2014(159):1239–1247View Article
  3. Bönsch C, Kempf C, Ros C (2008) Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity. J Virol 82:11784–11791View Article
  4. Sol N, Junter J, Vassias I, Freyssiner J, Thomas A, Prigent A et al (1999) Possible interactions between the NS-1 protein and tumor necrosis factor-alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 73:8762–8770View Article
  5. Zhi N, Mills I, Lu J, Wong S, Filippone C, Brown K (2006) Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity. J Virol 80:5941–5950View Article
  6. Morita E, Tada K, Chisaka H, Asao H, Sato H, Yaegashi N, Sugamura K (2001) Human parvovirus B19 induces cell cycle arrest at G2 phase with accumulation of mitotic cyclins. J Virol 75:7555–7563View Article
  7. Mortimer PP, Humphries RK, Moore JG, Purcell RH, Young NS (1983) A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature 302:426–429View Article
  8. Weigel-Kelley KA, Yoder MC, Chen L, Srivastava A (2006) Role of integrin cross-regulation in parvovirus B19 targeting. Hum Gene Ther 17:909–920View Article
  9. Weigel-Kelley K, Yoder M, Srivastava A (2003) Alpha-5 beta-1 integrin as a cellular co-receptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 102:3927–3933View Article
  10. Heegaard E, Brown K (2002) Human parvovirus B19. Clin Microbiol Rev 15:485–505View Article
  11. Erdman DD, Anderson BC, Torok TJ, Finkel TH, Anderson LJ (1997) Possible transmission of parvovirus B19 from intravenous immune globulin. J Med Virol 53:233–236View Article
  12. Miller E, Fairley CK, Cohen BJ, Seng C (1998) Immediate and long-term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 105:174–178View Article
  13. Santagostino E, Mannucci PM, Gringeri A, Azzi A, Morfini M, Musso R et al (1997) Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization. Transfusion 37:517–522View Article
  14. Kerr S, O’Keeffe G, Kilty C, Doyle S (1999) Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG. J Med Virol 57:179–185View Article
  15. Kudesia G, Wreighitt T (2005) Parvovirus B19. In: Kudesia G, Wreighitt T (eds) Clinical and diagnostic virology. Cambridge University Press, Cambridge, pp 90–93
  16. Corcoran A, Mahon BP, Doyle S (2004) B cell memory is directed towards conformational epitopes of parvovirus B19 capsid proteins and the VP1-unique region. J Infect Dis 189:1873–1880View Article
  17. Michel P, Makela A, Korhonen E, Toivola J, Hedman L, Söderlund-Venermo M et al (2008) Purification and analysis of polyhistidine-tagged human parvovirus B19 VP1 and VP2 expressed in insect cells. J Virol Methods 152:1–5View Article
  18. Modrow S, Wenzel J, Schimanski S, Schwarzbeck J, Rothe U, Oldenburg J, Jilg W et al (2010) Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates. Vox Sang 100:351–358View Article
  19. Brown KE, Young NS (1997) Human parvovirus B19: pathogenesis of disease. In: Anderson LJ, Young NS (eds) Monographs in virology, vol 20. Karger, Basel, pp 105–119
  20. Blümel J, Schmidt I, Effenberger W, Seiz H, Willkomnen H, Brackmann HH et al (2002) Parvovirus B19 transmission by heat-treated clotting factor concentrates. Transfusion 42:1473–1481View Article
  21. Wu CG, Mason B, Jong J, Erdman D, McKernan L, Oakley M et al (2005) Parvovirus B19 transmission by a high-purity factor VIII concentrate. Transfusion 45:1003–1010View Article
  22. Plentz A, Hahn J, Knoll A, Holler E, Jilg W, Modrow S (2005) Exposure of hematologic patients to Parvovirus B19 as a contaminant of blood cell preparations and blood products. Transfusion 45:1811–1815View Article
  23. Kumar S, Gupta RM, Sen S, Sarkar RS, Philip J, Kotwal A et al (2013) Seroprevalence of human parvovirus B19 in healthy blood donors. Med J 69(2013):268–272
  24. Al-Danani D, Abou-Donia H, Saudi M, Al-Shamahy H (2008) Seroprevalence of parvovirus B19 IgG among blood donors in Aden, Yemen and Alexandria, Egypt. J Chin Clin Med 3:173–176
  25. Tsujimura M, Matsushita K, Shiraki H, Sato H, Okochi K, Maeda Y (1995) Human parvovirus B19 infection in blood donors. Vox Sang 69:206–212View Article
  26. Wakamatsu C, Takakura F, Kojima E, Kiriyama Y, Goto N, Matsumoto K et al (1999) Screening of blood donors for human parvovirus B19 and characterization of the results. Vox Sang 76:14–21View Article
  27. Hsu TC, Chen TY, Lin MC, Tzang BS, Tsay GJ (2005) Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection. J Gastroenterol Hepatol 20:733–738View Article
  28. Khameneh ZR, Sepehrvand N, Sohrabi V, Ghasemzadeh N (2014) The seroprevalence of parvovirus B19 among kidney transplant recipients: a single-center study. Saudi J Kidney Dis Transpl 25(1):16–21View Article
  29. Azadmanesh K, Mohraz M, Monireh Kazemimanesh M, Aghakhani A, Foroughi M, Banifazl M et al (2015) Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV. J Med Virol 87:1124–1129View Article
  30. Sharif A, Aghakhani A, Velayati AA, Banifazl M, Sharif MR, Razeghi E et al (2016) Frequency and genotype of human parvovirus B19 among Iranian hemodialysis and peritoneal dialysis patients. Intervirology 59:179–185View Article
Metadata
Title
Screening for Human Parvovirus B19 Infection in Egyptian Family Replacement Blood Donors
Authors
Rabab Hasanain Ahmed Hasanain
Rania M. Saleh
Fadia M. Attia
Hanaa H. Gomaa
Publication date
01-04-2021
Publisher
Springer India
Keyword
Fifth Disease
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2021
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-020-01356-y

Other articles of this Issue 2/2021

Indian Journal of Hematology and Blood Transfusion 2/2021 Go to the issue

Short Communication

Efficacy, safety, and quality of life of generic and innovator ibrutinib in Indian CLL patients

Short Communication

Role of Therapeutic Plasma Exchange in Resolution of Hyperhemolysis in a Patient Living with HIV/AIDS (PLHA) Diagnosed with Paroxysmal Cold Haemoglobinuria: A Case Report”

Original Article

Response to Immunosuppressive Therapy in Acquired Aplastic Anaemia: Experience of a Tertiary Care Centre from Eastern India

Correspondence

Hb Brugg [HBA1:c.63C>A]: Report of an Ultra-Rare Variant Hemoglobin and Its Co-inheritance with Hb D-Punjab

Images

Unusual Visitor in Bone Marrow—Metastatic Malignant Melanoma

Correspondence

Myeloid Neoplasm with t(8;22)(p11;q11): A Mimicker of Chronic Myeloid Leukaemia in Blast Crisis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits